Literature DB >> 16971699

Infusion of platelets transiently reduces nucleoside overload in MNGIE.

M C Lara1, B Weiss, I Illa, P Madoz, L Massuet, A L Andreu, M L Valentino, Y Anikster, M Hirano, R Martí.   

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is caused by thymidine phosphorylase (TP) deficiency, which leads to toxic accumulations of thymidine (dThd) and deoxyuridine (dUrd). In this work, we report that infusion of platelets from healthy donors to patients with MNGIE restored transiently circulating TP and reduced plasma dThd and dUrd levels, suggesting that treatments to achieve permanent restoration of circulating TP such as allogeneic stem cell transplantation or gene transfer might be therapeutic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971699     DOI: 10.1212/01.wnl.0000239824.95411.52

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  42 in total

1.  Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Caterina Garone; Saba Tadesse; Michio Hirano
Journal:  Brain       Date:  2011-09-20       Impact factor: 13.501

Review 2.  CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Authors:  Michio Hirano; Caterina Garone; Catarina M Quinzii
Journal:  Biochim Biophys Acta       Date:  2012-01-18

3.  Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE.

Authors:  M Hirano; R Martí; C Casali; S Tadesse; T Uldrick; B Fine; D M Escolar; M L Valentino; I Nishino; C Hesdorffer; J Schwartz; R G Hawks; D L Martone; M S Cairo; S DiMauro; M Stanzani; J H Garvin; D G Savage
Journal:  Neurology       Date:  2006-09-13       Impact factor: 9.910

Review 4.  Inherited mitochondrial diseases of DNA replication.

Authors:  William C Copeland
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

Review 5.  Chronic intestinal pseudo-obstruction.

Authors:  Alexandra Antonucci; Lucia Fronzoni; Laura Cogliandro; Rosanna-F Cogliandro; Carla Caputo; Roberto De Giorgio; Francesca Pallotti; Giovanni Barbara; Roberto Corinaldesi; Vincenzo Stanghellini
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

Review 6.  Mitochondrial neuro-gastrointestinal encephalomyopathy presenting with recurrent bowel perforations and intra-abdominal abscesses.

Authors:  Yael Dreznik; Mordechai Gutman; Batia Weiss; Avinoam Nevler
Journal:  J Gastrointest Surg       Date:  2014-07-15       Impact factor: 3.452

7.  Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.

Authors:  J Halter; Wmm Schüpbach; A Gratwohl; M Hirano; C Casali; R Elhasid; K Fay; S Hammans; I Illa; L Kappeler; S Krähenbühl; T Lehmann; H Mandel; R Marti; H Mattle; K Orchard; D Savage; C M Sue; D Valcarcel
Journal:  Bone Marrow Transplant       Date:  2010-05-03       Impact factor: 5.483

Review 8.  Erythrocyte-mediated delivery of recombinant enzymes.

Authors:  Vincenzo Leuzzi; Luigia Rossi; Claudia Gabucci; Francesca Nardecchia; Mauro Magnani
Journal:  J Inherit Metab Dis       Date:  2016-03-30       Impact factor: 4.982

Review 9.  Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

Authors:  Ayman W El-Hattab; Fernando Scaglia
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

10.  Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk.

Authors:  C Lamperti; M Zeviani
Journal:  Acta Myol       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.